Repro Med Systems Inc (KRMD) - Total Assets
Based on the latest financial reports, Repro Med Systems Inc (KRMD) holds total assets worth $27.10 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Repro Med Systems Inc net assets for net asset value and shareholders' equity analysis.
Repro Med Systems Inc - Total Assets Trend (1996–2024)
This chart illustrates how Repro Med Systems Inc's total assets have evolved over time, based on quarterly financial data.
Repro Med Systems Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Repro Med Systems Inc's total assets of $27.10 Million consist of 70.3% current assets and 29.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 35.2% |
| Accounts Receivable | $6.00 Million | 22.0% |
| Inventory | $2.80 Million | 10.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $730.28K | 2.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2024)
This chart illustrates how Repro Med Systems Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Repro Med Systems Inc (KRMD) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Repro Med Systems Inc's current assets represent 70.3% of total assets in 2024, an increase from 49.0% in 1996.
- Cash Position: Cash and equivalents constituted 35.2% of total assets in 2024, up from 3.0% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 1996.
- Asset Diversification: The largest asset category is accounts receivable at 22.0% of total assets.
Repro Med Systems Inc Competitors by Total Assets
Key competitors of Repro Med Systems Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Repro Med Systems Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.48 | 2.99 | 10.24 |
| Quick Ratio | 1.92 | 2.37 | 8.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $11.59 Million | $12.60 Million | $33.86 Million |
Repro Med Systems Inc - Advanced Valuation Insights
This section examines the relationship between Repro Med Systems Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 12.29 |
| Latest Market Cap to Assets Ratio | 6.93 |
| Asset Growth Rate (YoY) | -4.4% |
| Total Assets | $27.22 Million |
| Market Capitalization | $188.53 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Repro Med Systems Inc's assets at a significant premium (6.93x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Repro Med Systems Inc's assets decreased by 4.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Repro Med Systems Inc (1996–2024)
The table below shows the annual total assets of Repro Med Systems Inc from 1996 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $27.22 Million | -4.37% |
| 2023-12-31 | $28.46 Million | -32.77% |
| 2022-12-31 | $42.33 Million | +2.52% |
| 2021-12-31 | $41.29 Million | +3.44% |
| 2020-12-31 | $39.92 Million | +187.56% |
| 2019-12-31 | $13.88 Million | +31.64% |
| 2018-12-31 | $10.55 Million | +13.62% |
| 2017-12-31 | $9.28 Million | +13.59% |
| 2016-12-31 | $8.17 Million | -0.29% |
| 2015-12-31 | $8.19 Million | +12.53% |
| 2014-12-31 | $7.28 Million | +17.27% |
| 2013-12-31 | $6.21 Million | +11.02% |
| 2012-12-31 | $5.59 Million | +16.38% |
| 2011-12-31 | $4.81 Million | +55.82% |
| 2010-12-31 | $3.08 Million | +29.00% |
| 2009-12-31 | $2.39 Million | +3.47% |
| 2008-12-31 | $2.31 Million | +95.79% |
| 2007-12-31 | $1.18 Million | +3.66% |
| 2006-12-31 | $1.14 Million | +24.15% |
| 2005-12-31 | $916.99K | -9.47% |
| 2004-12-31 | $1.01 Million | -14.76% |
| 2003-12-31 | $1.19 Million | +6.98% |
| 2002-12-31 | $1.11 Million | -20.62% |
| 2001-12-31 | $1.40 Million | -3.07% |
| 2000-12-31 | $1.44 Million | -8.33% |
| 1999-12-31 | $1.57 Million | -32.13% |
| 1998-12-31 | $2.32 Million | -42.43% |
| 1997-12-31 | $4.03 Million | +20.30% |
| 1996-12-31 | $3.35 Million | -- |
About Repro Med Systems Inc
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating p… Read more